Fresh funds mobilised by the GHIT Fund to further support the PfRipr5 malaria vaccine candidate
NEWS
News



- Jul 24
- 2 min
TRANSAVC2 concludes: key achievements and new horizons


- Jun 26
- 4 min
EVI co-led vaccinology course in Uganda, together with UVRI-IAVI


- Jun 21
- 2 min
UltiMalVax, a new highly collaborative project to develop the next generation malaria vaccine

- Jun 9
- 2 min
NOSEVAC, a new European collaboration to develop nasal vaccines

- Jun 7
- 1 min
TRANSVAC2 and the vaccine R&D infrastructure in the European Union


- Apr 28
- 1 min
Plasmodium falciparum infection can interfere with the immune response to BK-SE36 malaria vaccine


- Apr 25
- 2 min
World Malaria Day 2023

- Apr 24
- 2 min
Protecting the next generations with vaccines – World & European Immunization Week 2023

- Mar 13
- 1 min
Leishmaniasis - a Forgotten Epidemic

- Feb 10
- 2 min
International day of women and girls in science

- Jan 27
- 2 min
World NTD Day 2023: Act now. Act together.


- Jan 20
- 2 min
Antibody response to BK-SE36 vaccination is not impacted by African-specific SERA5 polymorphisms

- Dec 27, 2022
- 2 min
International day of epidemic preparedness 2022

- Dec 20, 2022
- 2 min
Dutch government pledges €17 Mio to EVI to advance malaria vaccines for pregnant women and children


- Dec 19, 2022
- 2 min
The WHO/TDR alumni meeting brings together EVI fellows in Cape Town

- Dec 5, 2022
- 3 min
Protecting the next generations with vaccines

- Nov 29, 2022
- 2 min
Latest results from EVI-led projects ShigEtecVax and ShigaPlexIM to be presented at the VASE 2022

- Nov 18, 2022
- 2 min
WAAW 2022: antimicrobial resistance, one of the biggest threats to human health

- Nov 2, 2022
- 2 min
Novel blood-stage malaria vaccine candidate, adjuvanted PfRipr5, to reach over 50% in vitro efficacy


- Sep 5, 2022
- 2 min
Blood-stage malaria vaccine candidate BK-SE36 shown to be safe and immunogenic in children

- Aug 30, 2022
- 4 min
EVI's new publication identifies gaps in outreach information on COVID-19 vaccine trials in Europe


- Aug 18, 2022
- 3 min
VAC2VAC, ‘Vaccine batch to vaccine batch comparison by consistency testing,’ successfully completed

- Jul 5, 2022
- 2 min
Asexual blood-stage malaria vaccine candidate PfRipr5: enhanced production in insect cells